However, various factors, including downregulated expression of c‐Kit on the cell surface, protease in the lysosomes, upregulated expression of anti‐apoptotic proteins, p53 mutation, and slow growth kinetics of cancer cells limit the therapeutic efficacy of microtubule inhibitors. This evidence concerns the gene TP53 and cancer.